Insulin resistance is associated to in-stent restenosis in Type 2 diabetic patients

被引：0
|
作者：
Magro, G
Procopio, M
Feola, M
Ribichini, F
Ferrero, V
Vado, A
Uslenghi, E
Borretta, G
机构：
[1] Dept Internal Med, Div Endocrinol, Azienda, Italy
[2] Div Cardiol, Cuneo, Italy
[3] Osped S Croce & Carle, Cuneo, Italy
来源：
DIABETOLOGIA | 2002年 / 45卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
18
引用
收藏
页码：A8 / A8
页数：1
相关论文
共 50 条
  • [11] Management of in-stent restenosis in diabetic patients: Balloon angioplasty, stent or rotational atherectomy?
    Moustapha, AI
    Vaughn, WK
    Assali, AR
    Sdringola, S
    Fish, RD
    Schroth, G
    Rosales, O
    Smalling, RW
    Anderson, HV
    CIRCULATION, 2000, 102 (18) : 731 - 731
  • [12] EVALUATION OF A DIABETIC RABBIT MODEL FOR IN-STENT RESTENOSIS
    Radke, P. W.
    Joost, A.
    Kaiser, A.
    Basler, M.
    Mandapathil, M.
    Weber, C.
    Yla-Herttuala, S.
    Ito, W.
    ATHEROSCLEROSIS SUPPLEMENTS, 2011, 12 (01) : 86 - 86
  • [13] Serum levels of advanced glycation end products are associated with in-stent restenosis in diabetic patients.
    Choi, EY
    Kwon, HM
    Ahn, CW
    Lee, GT
    Jung, B
    Yoon, YW
    Kim, D
    Byun, KH
    Kim, CS
    Kim, DM
    Kim, HS
    AMERICAN JOURNAL OF CARDIOLOGY, 2004, 94 (6A): : 46E - 46E
  • [14] The insertion/deletion polymorphism of the angiotensin I converting enzyme is not associated with in-stent restenosis in diabetic patients
    Debruyne, P
    Ferrero, V
    De Bruyne, B
    Heyndrickx, GR
    Wijns, W
    Matullo, G
    Uslenghi, E
    Ribichini, F
    EUROPEAN HEART JOURNAL, 2000, 21 : 397 - 397
  • [15] Increased glycated albumin and decreased esRAGE concentrations are associated with in-stent restenosis in Chinese diabetic patients
    Lu, Lin
    Pu, Li Jin
    Chen, Qiu Jing
    Wang, Linjie
    Peng, Wenhui
    Yan, Xiaoxiang
    Zhang, Qi
    Zhang, Rui Yan
    Gong, Pei Hua
    Qiu, Jian Ping
    Shen, Wei Feng
    CLINICA CHIMICA ACTA, 2008, 396 (1-2) : 33 - 37
  • [16] Predictors of the occurrence and type of in-stent restenosis
    Goldberg, SL
    Loussararian, A
    Ferraro, M
    Amato, A
    Martini, G
    CIRCULATION, 1998, 98 (17) : 434 - 434
  • [17] Rosiglitazone reduces in-stent restenosis in diabetic patients with coronary artery disease
    不详
    ANNALS OF INTERNAL MEDICINE, 2005, 143 (09) : 675 - 675
  • [18] Insulin resistance and in-stent restenosis: could modulating insulin improve outcomes of percutaneous coronary intervention?
    Armstrong, Ehrin J.
    McCabe, James M.
    CORONARY ARTERY DISEASE, 2015, 26 (01) : 1 - 2
  • [19] Association of Circulating IgE and CML Levels with In-Stent Restenosis in Type 2 Diabetic Patients with Stable Coronary Artery Disease
    Liu, Jingmeng
    Chen, Qiujing
    Lu, Lin
    Jin, Qi
    Bao, Yangyang
    Ling, Tianyou
    Lin, Changjian
    Ding, Fenghua
    Wang, Xiaoqun
    Shen, Weifeng
    Shen, Ying
    Dai, Yang
    Wu, Liqun
    JOURNAL OF CARDIOVASCULAR DEVELOPMENT AND DISEASE, 2022, 9 (05)
  • [20] In-stent coronary restenosis, but not the type of stent, is associated with impaired endothelial-dependent vasodilatation
    Mizia-Stec, Katarzyna
    Gasior, Zbigniew
    Haberka, Maciej
    Mizia, Magdalena
    Chmiel, Artur
    Janowska, Joanna
    Holecki, Michal
    Mietczarek, Marcin
    Zahorska-Markiewicz, Barbara
    KARDIOLOGIA POLSKA, 2009, 67 (01) : 9 - 18
12345